| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| KalVista Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 30,000 | 01 Oct 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| KALV | KalVista Pharmaceuticals, Inc. | 01 Oct 2025 | 1 | $0 | 4 | Director | 02 Oct 2025, 18:30 |
| KALV | KalVista Pharmaceuticals, Inc. | 03 Oct 2024 | 1 | $0 | 4 | Director | 04 Oct 2024, 16:07 |
| KALV | KalVista Pharmaceuticals, Inc. | 26 Sep 2023 | 1 | $0 | 4 | Director | 28 Sep 2023, 16:55 |
| KALV | KalVista Pharmaceuticals, Inc. | 26 May 2022 | 1 | $0 | 4 | Director | 27 May 2022, 16:18 |
| KALV | KalVista Pharmaceuticals, Inc. | 26 May 2022 | 0 | $0 | 3 | Director | 27 May 2022, 16:16 |